Market Research Logo

Informatics in Drug Discovery: The Evolving Information Technology Marketplace

Within the world of life science research, informatics plays a key role. A few years ago, this market space was occupied primarily by a few niche players, but over the past five years, established companies have expanded their offerings and hundreds of new software companies have surfaced.

In the rapidly changing field of informatics, it is difficult to decode the buzz-words, interpret the extravagant claims, separate true needs from blue-sky wishes. The concerns and strategies of only a year ago are old news. And new suppliers, products, strategies, and markets are now being established.

This study is designed to unravel the complexities of information technology as used in drug discovery. It also looks at information technology from the customers’ perspective, providing insights from leading pharmas and industry experts.

At one point, the informatics market for drug discovery was divided into two pieces: Cheminformatics and Bioinformatics. Each was served by a different group of suppliers with different products sold to different customers. However, it is getting more difficult to distinguish between software products that are designed for specific areas.

In the future, these distinctions may become irrelevant. For the purposes of this study, Kalorama has divided the market into four major product groups (to provide some shape to a very amorphous market):

  • Cheminformatics,
  • Bioinformatics,
  • In-silico modeling, and
  • Hardware and systems.

For each segment, the major issues and challenges are explored and the market size and growth are quantified through 2008. In addition, each chapter includes the estimated market share of the leading suppliers and a list of competing firms.

The report concludes with profiles of 30 suppliers of informatics products and services. Although these companies are a small percentage of all the companies in this market, they were selected to be representative. A balance was sought between very large corporations, very small start-ups, and mid-sized players. Each profile contains location, size, history, priority of their products for drug discovery, and their industry position and future strategic potential. Financial data are either reported (public companies) or estimated (private companies and subsidiaries).


Chapter One: Executive Summary

  • About Informatics
  • Definitions & Descriptions
  • Informatics Applications
  • Report Objectives & Structure
    • Key Questions Answered by this Report:
    • Organization of the Report

  • Results Summary
    • Answers to Key Questions
    • What’s Hot

Chapter Two: Markets, Views & Approaches

  • Informatics Markets
    • World Markets
    • Informatics Markets in Life Sciences

  • Different Views of the Informatics Market
    • Informatics in Drug Discovery: Year 2000
    • Informatics in Drug Discovery: Today
      • User Requirements
      • Supplier Strategies
      • The Bulls’ View of the Market
        • True Premises
        • Huge Market Potential
        • Market Segments
        • IBM Hypes Opportunities
        • The Bears’ View of the Market
          • Where’s the Market?
          • False Ideas
          • Suppliers
          • What Customers Want
          • Problems with Selling Software
          • Nature of Market

      • Expert Opinions: Interview Responses
        • Role of Informatics in Drug Discovery
        • Nature of Market
        • Future Expectations

      • Three Different Big Pharma Approaches
        • Novartis Builds a Research Center
        • Merck Refocuses and Consolidates
        • Johnson & Johnson Does Its ABCDs

Chapter Three: Cheminformatics Markets

  • Databases
  • Compound Synthesis & Management
    • Compound Synthesis
    • Library Design
    • Compound Management

  • Data Analysis
  • Information Integration
  • Market Analysis

Chapter Four: Bioinformatics Markets

  • Software Applications in Life Sciences
  • Bioinformatics in Drug Discovery
  • Databases for Bioinformatics
  • Data Acquisition and Integration
    • Integrating Screening Results
    • Information from Sequence Analysis
    • Mass Spec Analysis
    • Informatics and ‘Omics’

  • Data Mining & Analysis
    • Mining for information
    • Text Mining
    • Data Mining for ADMET Prediction
    • Infrastructure
    • Pathways Analysis

  • Targets & Structure
    • Target Selection
    • Connecting Structure with Activity
    • Visualization & Biomarkers

  • Market Analysis

Chapter Five: In-Silico Modeling

  • Compound Structure Modeling
    • Approaches to Structural Modeling: Homology, Threading, and Ab Initio.
    • In-silico SAR
    • Examples of Modeling Tools
    • Modeling Success Story

  • Lead Opt: Screening and ADMET Prediction
    • Virtual Screening
    • Early ADMET Prediction
    • ADME / Tox Predictive Software Products

  • Target Validation & Binding Models
    • Modeling Products for Target Validation & Binding
    • Target Validation Breakthrough

  • In-Silico Modeling Markets

Chapter Six: Hardware & Systems

  • Instrument Operation & Control
    • Automation Evolution
    • Lab Instrument Control Software
    • Future Developments

  • Laboratory Information Management Systems
    • Suppliers & Products

  • Electronic Laboratory Notebooks
    • ELN Suppliers & Products
    • Satisfied Users of ELNs

  • High Performance Computing (HPC)
    • Giants’ Strategies
    • Approaches to HPC
    • HPC Products & Suppliers
    • New Giant Enters HPC: Microsoft

  • Market Analysis

Chapter Seven: Company Profiles

  • Overview
    • Corporate Demographics
    • Location
    • Type of Company
    • Age
    • Revenues
    • About these Suppliers

  • Accelrys
    • Company Background
    • Financials
    • SciTegic Acquisition
    • Software Products
    • Life Science Modeling
    • Cheminformatics
    • Bioinformatics
    • Approaches to Market

  • Advanced Chemistry Development
    • Company Background & Orientation
    • Focus on Drug Discovery
    • Drug Discovery Products
    • Drug Discovery Applications
    • Strategies and Approach to Market

  • Applied Biosystems
    • Company Background
    • Financials Informatics Software

  • Beckman Coulter, Inc.
    • Background & History
    • Financials
    • Systems & Informatics Products
    • Approach to Market

  • Bio-Rad Laboratories
    • Company History & Focus
    • Financials
    • Informatics / Sadtler Group
    • KnowItAll Cheminformatics System
    • Future Directions

  • CambridgeSoft
    • Background & History
    • Product Lines
    • Drug Discovery Products
    • Strategies & Capabilities

  • Cellomics
    • Background & History
    • Products for HCS
    • High Content Informatics Platform (HCi)
    • Future Opportunities

  • Centient Consulting, Inc.
    • Background & History
    • Informatics Services

  • Chemical Computing Group (CCG)
    • Company Focus
    • MOE for Life Science Research

  • Compugen
    • History & Focus
    • Financials
    • Informatics Products

  • De Novo Pharma
    • Background
    • Cheminformatics Platform: Skelgen
    • Current Approach & Future Directions

  • GE Healthcare (Amersham Biosciences + GE Medical Systems)
    • Background & History
    • GE and Amersham Business Units & Financials
    • Amersham in Informatics

  • Gene Go
    • Background & History
    • MetaCore and MetaDrug for drug discovery
    • GeneGo Strategy and Future

  • Gene Logic
    • Background & History
    • Financials
    • Products & Services
    • Drug Discovery Products & Services
    • Directions & Strategies

  • Green Mountain Logic
    • History & Background
    • LabPAS Adaptive LIMS
    • Future Products: Green Mountain & AI?

  • IBM Life Science Solutions
    • Background & History
    • Areas of Focus
    • Drug Discovery Products & Services
    • Approach to the Market

  • ID Business Solutions Ltd. (IDBS)
    • Background & History
    • Areas of Focus
    • Drug Discovery Products
    • Approach to the Market

  • InforSense Ltd.
    • Background & History
    • Open Discovery Workflow Product Line

  • Ingenuity Systems
    • Background
    • Pathways Software Products
    • Marketing Activities

  • Inpharmatica
    • Background & History
    • PharmaCarta Software

  • Invitrogen
    • Background & History
    • Financials
    • Acquisition of InforMax
    • Invitrogen Bioinformatics

  • Leadscope
    • Background & Focus
    • Software and Databases
    • Leadscope Seminar on Data Mining
    • Future Directions

  • LION Bioscience AG
    • Company History & Focus
    • Financial Picture
    • Drug Discovery Software
    • Future Viability

  • MDL Information Systems
    • Company History & Focus
    • Information Systems Product Lines
    • Approach to Market

  • Molecular Devices
    • Background & History
    • Financials
    • Drug Discovery Systems & Software

  • Simulations Plus
    • Background & History
    • Financials
    • ADME Prediction Software

  • Spotfire
    • Background & History
    • Financials
    • DecisionSite in drug discovery

  • Sun Microsystems
    • History & Focus
    • Sun Products & Services
    • Sun in Bioinformatics

  • Tripos
    • Company History & Focus
    • Financials
    • Discovery Software
    • Approach to Market

  • TurboWorx
    • History & Focus
    • TurboWorx Approach
    • Examples of their Workflow Solutions
    • Tools for Life Sciences
    • Future Opportunities

List of Exhibits

Chapter One: Executive Summary

  • Table 1-1: Market Summary: Informatics Product Markets 2004
  • Table 1-2: Market Summary: Market Growth by Product Area
  • Table 1-3: Market Summary: Market Leaders by Product Area 2004

Chapter Three: Cheminformatics Markets

  • Table 3-1: Tripos and Informatics-Driven Drug Discovery
  • Table 3-2: Worldwide Cheminformatics Market Size by Product Area 2004
  • Table 3-3: Worldwide Cheminformatics Market Growth and 2008 Forecast by Product Area
  • Table 3-4: Leading Chemoinformatics Suppliers and Market Shares 2004
  • Table 3-5: Cheminformatics Suppliers

Chapter Four: Bioinformatics Markets

  • Table 4-1: Worldwide Bioinformatics Markets Size by Product Area 2004
  • Table 4-2: Worldwide Bioinformatics Market Growth and 2008 Forecast by Product Area
  • Table 4-3: Leading Bioinformatics Suppliers and Market Shares 2004
  • Table 4-4: Bioinformatics Suppliers

Chapter Five: In-Silico Modeling

  • Table 5-1: Pros and Cons of In-silico Modeling
  • Table 5-2: Traditional vs. Modeling Approaches
  • Table 5-3: Worldwide In-Silico Modeling Market Size by Product Area 2004
  • Table 5-4: Worldwide In-Silico Modeling Market Growth and 2008 Forcast by Product Area
  • Table 5-5: Leading In-Silico Modeling Suppliers and Market Shares 2004
  • Table 5-6: In-Silico Modeling Companies

Chapter Six: Hardware & Systems

  • Table 6-1: LIMS Alternatives: “Build, Buy, or Both” Decisions by Specific Issue
  • Table 6-2: Worldwide Informatics Hardware & Systems Market Size by Product Area 2004
  • Table 6-3: Worldwide Informatics Hardware & Systems Market Growth and 2008 Forcast by Product Area
  • Table 6-4: Leading Informatics Hardware and Systems Suppliers and Market Shares 2004
  • Table 6-5: Hardware & Systems Companies

CHapter Seven: Company Profiles

  • Table 7-1: Summary of Companies Profiled: Location, Type, Founded Date, Revenues, Product Types

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report